The risk factors for nosocomial infection in chinese patients with active rheumatoid arthritis in shanghai.
Xie WL , Li ZL , Xu Z , Qu HR , Xue L , Su X , Wei QH , Wang H , Li MY , Zhao FT , Jiang LD , Zhang J , Wan WG , Dai M , Yang CD , Guan JL , Su L , Zhao DB , He DY , Xu HJ , Zou HJ , Bao CD 
ISRN Rheumatol.2012 ; 2012():215692.
PubMedで表示
Google翻訳で開く
Department of Rheumatology and Immunology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
(88view , 0users)
Full Text Sources
Objective. To analyse the potential risk factors of nosocomial infections in patients with active rheumatoid arthritis (RA). Methods. A total of 2452 active RA patients at Hospitals in Shanghai between January 2009 and February 2011 were analyzed. Their demographic and clinical characteristics were compared with those without infection, and the potential risk factors were determined by logistic regression analysis. Results. Multivariate analysis indicated the gender (OR = 0.70, 95% CI 0.53-0.92), duration in hospital (OR = 1.03 , 95%CI 1.01-1.05), number of organs involved (OR = 0.82, 95%CI 0.72-0.92), number of disease-modifying antirheumatic drugs ((DMARDs) (OR = 1.22, 95%CI 1.061-1.40)), corticosteroid therapy (OR = 1.02, 95%CI 1.01-1.03), peripheral white blood cell counts ((WBC) (OR = 1.04, 95%CI 1.00-1.08)), levels of serum albumin (OR = 0.98, 95%CI 0.97-0.99), and C-reactive protein ((CRP) (OR = 1.03 , 95%CI 1.01-1.04)) that were significantly associated with the risk of infections. Conclusion. The female patients, longer hospital stay, more organs involved, more DMARDs, corticosteroid usage, high counts of WBC, lower serum albumin, and higher serum CRP were independent risk factors of infections in active RA patients.
PMID: 22548187 [PubMed - in process]
PMID: 22548187 [PubMed - in process]
機械翻訳を行う(ログインが必要です)
関連論文
- A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
- Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
- Final Report on Carcinogens Background Document for Formaldehyde.
- Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs.